News Archive - School of Medicine

Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests

UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.

You’ve Got to Move It, Move It

Research from Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego suggests that light-intensity physical activity, including shopping or a casual walk, may protect against mobility disability in older women.

Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups

Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.

Last-Itch Effort: Fighting the Bacteria That Exacerbate Eczema with Bacteria

Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis.

First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease

UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.

Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors

Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.

Genetics May Play Role in Determining Immunity to COVID-19

UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.

New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain

The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.

Leading Experts Call for Immediate Action to Address Inhalation Exposure to Prevent COVID-19

Leading scientific and medical experts, including researchers from the University of California San Diego, are calling upon the Biden Administration to take immediate action to address inhalation exposure to the SARS-CoV-2 virus as a cornerstone of the COVID-19 pandemic response.

Existing Heart Failure Drug May Treat Potential COVID-19 Long-Hauler Symptom

UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.